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Abstract
Introduction: Influenza continues to be a considerable
health problem in Europe. Vaccination is the only preventive
measure, reducing mortality and morbidity of influenza in all
age groups.
Objectives: The objective of this survey was to assess and
compare the level of influenza vaccination coverage during
three consecutive influenza seasons (02/03, 03/04, 04/05)
in the five European countries United Kingdom, France,
Italy, Germany and Spain, understand the driving forces
and barriers to vaccination now and 3 years ago and
determine vaccination intentions for the following winter.
Methods: We conducted a random-sampling, telephone-
based household survey among non-institutionalized
individuals representative of the population aged 14 and
over. The surveys used the same questionnaire for all
three seasons. The data were subsequently pooled. Four
target groups were determined for analysis: (1) persons
aged 65 and over; (2) people working in the medical field;
(3) persons suffering from chronic illness and (4) a group
composed of persons aged 65 and over or working in the
medical field or suffering from a chronic illness.
Results: The overall sample consisted of 28,021 people.
The influenza vaccination coverage rate increased from
21.0% in season 02/03 to 23.6% in season 03/04 and
then to 23.7% in season 04/05. The differences between
the seasons are statistically significant (p = 0.01). The
highest rate over all countries and seasons had Germany
in season 04/05 with 26.5%, Spain had in season 02/03
with 19.3% the lowest rate totally. The coverage rate in
the target group composed of person’s aged 65 and over
or working in the medical field or suffering from a
chronic illness was 49.7% in season 02–04 and 50.0% in
season 04/05. The driving forces and barriers to
vaccination did not change over the years. The most
frequent reasons for being vaccinated given by vaccines
were: influenza, considered to be a serious illness which
people wanted to avoid, having received advise from the
family doctor or nurse to be vaccinated and not wanting
to infect family and friends. Reasons for not being
vaccinated mentioned by people who have never been
vaccinated were: not expecting to catch influenza, not
having considered vaccination before and not having
received a recommendation from the family doctor to be
vaccinated. Options encouraging influenza vaccination
are: recommendation by the family doctor or nurse, more
available information on the vaccine regarding efficacy
and tolerance and more information available about the
disease. The adjusted odds ratio of receiving influenza
vaccine varied between 2.5 in Germany and 6.3 in the
United Kingdom in any risk group.
Conclusion: The vaccination coverage rate increased
from the first season (21.0%) to the third season
(23.7%) by 2.6%. The family doctor is the most
important source of encouragement for people to be
vaccinated against influenza. It seems that the public
would be more likely to be vaccinated if they had more
information on the efficacy and tolerance of the
vaccine, as well as the disease. We therefore suggest
that family doctors be better informed on influenza
vaccine and the disease itself, so that they can actively
inform their patients on these topics.
Infection 2007; 35: 308–319
DOI 10.1007/s15010-007-6218-5
Introduction
Influenza is often seen as a problem-free and self-limiting
disease despite putting a high burden on patients as well as
being of high socio-economic relevance to society [1]. It
continues to be a considerable health problem in Europe.
Influenza is a major cause of morbidity and mortality
affecting up to 25% of the population each year [2]. The
typical case of influenza may be characterized by the abrupt
onset of fever, sore throat, non-productive cough, myalgias,
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headache and malaise. Symptoms usually last for 5–6 days.
Elderly and other high-risk persons are especially vulner-
able to the serious complications of influenza [2].
Vaccination is an effective way of reducing the mor-
tality and morbidity of influenza especially in the elderly
and patients with high-risk conditions [3]. Vaccination can
prevent about 50% of deaths from pneumococcal disease
and 80% of deaths from influenza-related complications
in the elderly [4]. In addition to providing substantial
health benefits, vaccination may also be associated with
significant economic benefits, not only among the elderly
but also among healthy working adults and even children.
Healthy working adults traditionally have not been in-
cluded among the priority groups targeted for annual
influenza vaccination. Fewer than 25% of the persons
aged between 18 and 64 years received an influenza vac-
cination during 1997. Nevertheless, the effect of influenza
on this group is also substantial. Influenza vaccination of
healthy working adults is, on average, cost saving [2].
In general, population-based studies of influenza
vaccination coverage for a country do not exist. A Cana-
dian study found 13.8% influenza vaccination coverage in
fall and winter 1990–1991 [5]. Most studies on influenza
vaccination coverage investigate specific groups such as
the elderly [6–15], patients from general practices [16, 17],
or hospitalized patients [18].
The official recommendations in all of the five
countries studied are the same: age > 65, chronic illness
[cardiovascular, respiratory, diabetes mellitus, renal,
immunology, HIV (except Italy)], nursing home residents
and health care workers [19].
In order to monitor the changes in vaccination cov-
erage rates and behaviours in comparison to previous
seasons (2002–2003 and 2003–2004), this survey was re-
peated during winter 2004–2005.
Objectives
The primary aim of this study is to identify the level of
influenza vaccination coverage in three consecutive
influenza seasons in five European countries. We also
wanted to know whether coverage was associated with
demographic parameters.
The second objective is to understand the determi-
nants for being vaccinated or not and to obtain the pop-
ulation’s opinion on influenza and vaccination. A further
objective was to examine the options, which encourage
people to be vaccinated and to find out their vaccination
intentions for the following winter. Furthermore it is
important to see, which determinants for being vaccinated
have changed in the last years.
Methods
This study is a population-based survey performed during three
consecutive influenza-seasons (02/03, 03/04 and 04/05 for Ger-
many, Italy, Spain and the United Kingdom and 02/03 and 04/05
for France. The questionnaire (see Appendix) was circulated via
telephone omnibus among non-institutionalized individuals rep-
resentative of the population, between December and January.
Mobile phones were not included. For France, data were based on
the yearly survey by GEIG (Groupe d’Etude et d’Information sur
la Grippe) carried out by mail. The questions were identical in all
three seasons. The list of possible answers with respect to deter-
mining driving forces and barriers to vaccination, as well as
encouragement to be vaccinated, is inserted in table 1.
Table 1
Overview of the possible answers (more than one answer
possible).
Why did you get vaccinated this winter?
• Because it’s free : the Social Security pays for it
• So that I do not pass the flu bug to my family and friends
• Because flu is a serious illness and I did not want to get it
• The doctor at work offered to do it for me
• My family doctor/nurse advised me to do it
• My pharmacist advised me to do it
• Because of my age
• Because I am not in very good health
• To prevent the flu from interrupting my professional activities
• Because it is required/indicated for my job
• Because I got the flu last year
• Other reasons
• Do not know/no answer
Why do you not get vaccinated against the flu?
• I do not think I am very likely to catch the flu
• I thought about it but I did not end up getting vaccinated
• My family doctor has never recommended it to me
• My doctor at work has never recommended it to me
• My pharmacist has never recommended it to me
• I got the flu before, even though I had been vaccinated
• It is not a serious enough illness
• I do not think the vaccine is effective enough
• I do not like injections/needles
• I have never considered it before
• There is a new treatment which helps cure the flu
• I am too young to be vaccinated
• I am against vaccinations
• It is too complicated to get vaccinated
• It is too expensive, it is not reimbursed
• Other reasons
• Do not know/no answer
Which of the following options would encourage you to
be vaccinated against flu ?
• If I could be vaccinated at work
• If my doctor/nurse recommended it to me
• If my pharmacist recommended it to me
• If there were other ways of administering the vaccine
(orally, injection without a needle, etc.)
• If it were cheaper
• If I had more information on the vaccine regarding
efficacy and tolerance
• If I knew more about the disease
• If there were more reports in the media saying to get it done
• I would not change my mind, I would never be vaccinated
• Other
• Do not know/no answer
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The response rates were similar in the various countries over
time. In order to obtain highest possible response rates, the same
interviewers were utilized for this project. These interviewers
knew how to motivate possible study participants and meet any
objectives, which were raised in the recruiting phase. In addition,
primarily unanswered phone calls were followed up as much as
possible and in new appointments were scheduled in situations
where respondents were unable to set aside time at the first
encounter.
For each respondent, the following parameters were collected
in the survey: gender, age, city size, size of household, household
income, whether participants work in a medical field or suffer from
a chronic illness (such as heart or lung disease, diabetes or others).
As well as studying each parameter separately, we also defined
four target groups based on recommendations in Europe at the
time of the survey. The target groups were:
• all individuals aged 65 and over
• all individuals who suffer from a chronic illness
• all individuals who work in the medical field
• all individuals aged 65 and over or suffer from a chronic
illness or who work in the medical field.
The data were pooled and weighted for age and gender. Sta-
tistical evaluation was performed using the statistic program
SPSS (Statistical Package for the Social Sciences). Bivariate
associations of categorical variables were analyzed using Chi-
square tests. In case of one continuous variable, a T-test or
Mann–Whitney tests was used, depending on the kind of dis-
tribution observed. In all cases, p = 0.05 was used as the level of
statistical significance. Where applicable, odds ratios were cal-
culated from 2 · 2 tables, including 95% confidence intervals.
Predictor variables with strong associations (p < 0.02) were
considered candidates for multivariable analyses to identify the
independent correlates of the outcome of interest, i.e., vacci-
nation coverage. To develop the explanatory variables we used
the following analytic strategy: the dependent variable vaccina-
tion rate. Using multiple logistic regression techniques we
evaluated each predictor separately at the beginning and then
proceeded to build multivariable models that included several of
them at a time. Backward elimination and forward selection
procedures were used in order to assess the relative importance
of the predictors and derive a
parsimonious model. Only
models with adequate good-
ness-of-fit characteristics were
presented.
Results
Demographic Data
The overall sample con-
sisted of 28,021 persons.
An overview of the sample
is given in table 2. The
samples are representative
of the country’s adult
population.
Vaccination Rate
The vaccination coverage
rate in all surveyed countries increased from 21.0% in
season 02/03 to 23.6% in season 03/04, and again in season
04/05 to 23.7%. The differences between the seasons are
statistically significant (p = 0.001). The differences be-
tween the countries are only significant in season 04/05
(p = 0.001). Over all three seasons, Germany had the
highest population vaccination coverage rate in season 04/
05 (26.5%). The lowest vaccination rate was in Spain in
season 02/03 with 19.3%. The best increment was also in
Germany, the vaccination rate increased from 22.3% in
season 02/03 to 26.5% in season 04/05. The time trend
over the seasons was statistically significant for the UK
(Chi-square test for trend, p = 0.007), Germany
(p = 0.04), Spain (p = 0.05) and France (p = 0.001), but
not for Italy (p = 0.2) (Figure 1).
For the subsequent winter (05/06) 31% of the
respondents intend to be vaccinated against influenza. In
the season 02/03 32% of the people wanted to get vacci-
nated for the next season, but the vaccination rate of the
season 03/04 was lower than expected (24%). In season
03/04 34% wanted to obtain the vaccination, but only 24%
received the vaccination in season 04/05 (Figure 2).
Vaccination Coverage in Target Groups
The vaccination coverage rate for the group aged 65 and
over remained stable over the entire period, as 61.5% in
the seasons 02–04 and 63.7% in 04/05. This was signifi-
cantly different from the population under 65, where the
vaccination coverage rates reached 13.8% (02–04,
p = 0.001) and 14.8% (04/05, p = 0.001). The influence of
age is clearly apparent in figure 3: the older the people,
the higher the vaccination coverage rate. The group suf-
fering from chronic illness recorded a significantly higher
vaccination coverage rate than the group not suffering
from chronic: 49.6% vs 20.2% respectively during 02–04
(p = 0.001) and 52.8% vs 18.3% in the season 04/05
(p = 0.001). Individuals with a chronic illness older than
Table 2
Overview of samples.
United
Kingdom
Germany Italy France Spain All
Age cut-off (years) > 16 > 14 > 14 > 15 > 15
02/03 members 2,020 1,990 2,005 1,997 2,034 10,046
03/04 members 2,026 2,006 2,005 2,000 8,037
04/05 members 2,005 1,994 2,002 1,937 2,000 9,938
Number of participants 6,051 5,990 6,012 3,934 6,034 28,021
Mean age (years) 45.5 47.0 44.4 45.7 41.7 44.8
Aged 65 and over 19.0% 21.8% 16.5% 19.8% 12.3% 17.7%
Male 48.7% 47.8% 48.6% 48.0% 49.6% 48.5%
Work in medical field 7.4% 6.6% 3.8% 6.5% 4.3% 5.7%
Chronic illness 8.6% 15.8% 7.8% 7.2% 8.8% 9.8%
Target group: 65 and over
or chronic illness or
work in medical field
30.8% 36.8% 24.5% 30.0% 22.4% 28.8%
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65 years have a higher vaccination rate (76.1%) than
those under 65 years (38.0%). During the seasons 02–04
the fact of working in the medical field did not seem to be
a driving force for vaccination uptake as the vaccination
coverage rate in this population (22.4%) is almost equal to
the coverage rate in the non medical-professional group
(22.1%) (p = 0.946). In 04/05 the difference between
people who worked in the medical field and those who did
not is also not statistically significant (23.5% vs 23.7%,
p = 0.919). Concerning the people who are above 65 years
or suffer from chronic illness or work in a medical field,
representing the major combined target population for
influenza vaccination, the rate was 49.7% in the season
02–04 and 50.0% in the season 04/05.
The vaccination rate did not seem to be associated
with gender. Women had an vaccination rate of 22.8% in
season 02–04 and 24.0% in season 04/05. Men had a rate
of 21.4% and 23.5% (Table 3).
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Figure 1. Vaccination rates per country.
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Figure 2. Vaccination next winter: do you intend to be vaccinated
against influenza next winter?
Table 3
Vaccination coverage in target groups.
Vaccination rate
02–04 (%)
Vaccination rate
04/05 (%)
Gender
Male 21.4 23.5
Female 22.8 24.0
p-valuea 0.026 0.540
Age: years
< 65 13.8 14.8
> 65 61.5 63.7
p-valuea 0.001 0.001
Chronic illness
Yes 49.6 52.8
Yes, < 65 39.5 38.0
Yes, > 65 67.7 76.1
No 20.2 18.3
p-valuea 0.001 0.001
Work in medical field
Yes 22.4 23.5
No 22.1 23.7
p-valuea 0.879 0.919
Target group: 65 and over or chronic illness or work in medical field
Yes 49.7 50.0
No 11.2 12.0
p-valuea 0.001 0.001
a Chi square test
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Figure 3. Profile of vaccinated population by age groups.
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Questions about the Vaccination
For those who were vaccinated during the last season, the
most frequently stated reasons for being vaccinated were
advice received from the family doctor or nurse (55.2%
(02–04) and 50.6%(04/05)), influenza being considered as
a serious illness which people wanted to avoid (55.8%
(02–04) and 49.3% (04/05)), age (34.8 % and 34.8%) and
not wanting to infect family and friends (36.1% and
32.1%). People with a chronic illness and people over
65 years have the same reasons. Driving forces for medi-
cal staff were not to interrupt their professional activities,
indication for the job and offer of the doctor at work
(Table 4).
For those who have never been vaccinated, reasons
against vaccination were: not expecting to catch influenza
(40.4% and 36.7%), never having considered vaccination
before (33.3% and 31.3%) and the fact that the family
doctor has never recommended it (27.3% and 23.2%). For
the target groups side-effect problems with a previous
influenza vaccine, getting the flu before, even though they
had been vaccinated and not think the vaccine is effective
enough are further reasons (Table 5).
Most of the respondents agreed with the following
opinions about the vaccine:
• You can catch influ-
enza even if you are
vaccinated against it.
• If you catch the flu
after having had the
vaccine, the infection
is less severe.
• The side effects associ-
ated with the vaccine
(fever, headache, ...) are
acceptable.
• It is important to get
the influenza vaccine
each year.
Most of participants did
not agree to the following
opinions: the vaccine is not
useful if you are in good
health and if you have the
vaccine, you will not catch
influenza (Table 6).
Options, which encour-
age vaccination against
influenza are more avail-
able information about the
vaccine regarding efficacy
and tolerance (32.1% and
56.0%), a recommenda-
tion by the family doctor
or nurse (53.1% and
46.9%), more information on the disease (26.7% and
22.9%) (Table 7).
Likelihood of High-Risk Groups Receiving
Vaccination Across Countries
Large variations exist in the likelihood of high-risk
individuals (i.e., elderly over 65, health care workers
and people with chronic illnesses) receiving influenza
vaccine between countries. The adjusted odds ratio of
receiving influenza vaccine varied between 2.5 in
Germany and 6.3 in the United Kingdom in any risk
group (factor between the lowest and the highest
likelihood = 1.2). Table 8 displays an overview of the
likelihood of vaccination in these groups according to
country for the 2004/5 season.
Discussion
This survey was performed internationally (France, Uni-
ted Kingdom, Italy, Spain, Germany) for three consecu-
tive seasons. We believe a telephone survey is an
appropriate method in establishing influenza vaccination
coverage rates in different groups of the population. It can
be started at short notice, it is an easy way to reach a large
number of subjects rapidly, does not extend over more
Table 4
Questions put to people who have been vaccinated: ‘‘Why did you get vaccinated this winter?’’.
The most frequently stated reasons (%) 02–04 04/05
Because influenza is a serious illness and I did not want to get it 55.8a 49.3a
My family doctor/nurse advised me to do it 55.2a 50.6a
Because of my age 34.8 34.8a
So that I do not pass influenza bug to my family and friends 36.1a 32.1
Because it’s free: the Social Security pays for it 28.1 24.0
Because I am not in very good health 22.9 26.1
Chronic illness, under 65 years
My family doctor/nurse advised me to do it 53.7
Because I am not in very good health 49.4
Because influenza is a serious illness and I did not want to get it 45.0
So that I do not pass influenza bug to my family and friends 26.9
Because it’s free: the Social Security pays for it 23.4
Working in medical field
To prevent influenza from interrupting my professional activities 40.8
Because influenza is a serious illness and I did not want to get it 40.7
So that I do not pass influenza bug to my family and friends 40.2
Because it is required/indicated for my job 37.5
My family doctor/nurse advised me to do it 30.8
The doctor at work offered to do it for me 28.5
Older age, > 65 years
My family doctor/nurse advised me to do it 58.6
Because of my age 56.9
Because influenza is a serious illness and I did not want to get it 54.8
So that I do not pass influenza bug to my family and friends 31.6
Because it’s free: the Social Security pays for it 29.9
Because I am not in very good health 23.4
a Main three reasons stated amongst the different groups
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than a few weeks and can be repeated over several
influenza seasons.
Several limitations of the present evaluation are
acknowledged. The most important potential reason of
selection bias despite correct sampling is non-response.
Comparisons of face-to-face, mailed and telephone sur-
veys addressing health-related issues showed small dif-
ferences between modes of administration and small non-
response effects with respect to prevalence estimates [20,
21]. Non-response in tele-
phone surveys was found
to be less content-oriented
than in mailed surveys
[22]. Also, bias due to dif-
ferent sociodemographic
characteristics of people
not accessible by tele-
phone affected reports of
illness and related use of
services only marginally, if
the general population was
addressed and telephone
coverage was at least 90%
[22, 23]. People living in
institutions could not be
included, which would be
critical in the study of a
disease affecting higher
age groups differentially or
directly causing institu-
tionalization. Not having
asked the chronic illness
question during the 2002/
2003 season may have af-
fected the chronic illness
figures. However, it is
hypothesized that this im-
pact is minimal as the re-
sponses would have been similar for both seasons. One
bias could emerge from over- or under-reporting for
chronic illness.
We estimate, for Europe, that approximately 24% of
the population studied > 15 years of age had been vacci-
nated against influenza for the 2004/5 influenza season
respectively. This percentage corresponds approximately
to the 20% maximum estimate for the immunization rate
for the entire population calculated from the number of
Table 5
Questions asked to those who have never been vaccinated: ‘‘Why do you not get vaccinated
against influenza?’’.
The most frequently stated reasons (%) 02–04 04/05
I do not think I am very likely to catch influenza 40.4a 36.7a
I have never considered it before 33.3a 31.3a
My family doctor has never recommended it to me 27.3a 23.2a
I am too young to be vaccinated 23.0 22.1
It is not a serious enough illness 20.0 16.5
I thought about it but I did not end up getting vaccinated 14.4 12.8
Chronic illness, under 65 years
I thought about it but I did not end up getting vaccinated 33.9
I had side-effect problems with a previous flu vaccine 25.4
I got the influenza before, even though I had been vaccinated 25.3
I have never considered it before 22.1
My family doctor has never recommended it to me 21.6
Working in medical field
I thought about it but I did not end up getting vaccinated 39.5
I got the influenza before, even though I had been vaccinated 30.4
I had side-effect problems with a previous flu vaccine 21.4
I do not think the vaccine is effective enough 20.2
Older age, > 65 years
I thought about it but I did not end up getting vaccinated 27.9
I had side-effect problems with a previous flu vaccine 27.0
I have never considered it before 24.0
I got the influenza before, even though I had been vaccinated 22.1
I do not think the vaccine is effective enough 21.3
a Main three reasons stated amongst the different groups
Table 6
Opinions about influenza vaccine (%).
% Totally
agree
Quite
agree
Do not
really agree
Do not
agree at all
Do
not know
You can catch influenza even if you are vaccinated against it. 02–04 42.1 37.4 9.8 4.7 6.1
04/05 30 27.2 6.9 3.3 32.6
If you catch influenza after having had the
vaccine, the infection is less severe.
02–04 32.6 36 12.9 8.4 10.1
04/05 22.3 25.7 9.3 6.2 36.4
The side effects associated with the vaccine
(fever, headache, etc.) are acceptable.
02–04 22.4 30 19.6 13.6 14.4
04/05 16.6 20.1 13.4 9.7 40.1
If you have the vaccine you won’t catch influenza. 02–04 9.3 19.4 32.3 33.9 5.2
04/05 7 14.8 22.6 23.4 32.2
The flu vaccine is not useful if you are in good health. 02–04 19.7 22.4 26.6 25.2 6.2
04/05 14.1 16.4 18.5 18.3 32.6
It is important to get the flu vaccine each year. 02–04 28.9 27.7 23 15.6 4.8
04/05 22.5 20.7 14.6 10.7 31.5
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vaccine doses sold for the 2002–2004 immunization peri-
od, assuming all doses sold were given (90 million doses
for the 2002–2004 influenza vaccination period in Europe;
data provided by the suppliers) [24].
Vaccination coverage in the five countries together
increased during the 04/05 season relative to the 02/03
season (23.7% vs 21.0%). This increase was statistically
significant and concentrated in all but one age group
(> 90 years). Regarding the surveyed populations across
Europe, the German population over 15 years of age has
the highest vaccination coverage rate in Europe: 26.5%
(04/05). It needs to be mentioned however that this is
due to higher vaccination coverage of the adult working
population. Italy has the lowest over 15 population
vaccination with 20.8% (04/05). In comparison to other
European countries the vaccination rate of 23.7% may
be judged to adequate. The Netherlands reported a
vaccination rate of 24% [25], Poland 10% and Sweden
11% [26].
For the subsequent
winter 05/06 31% of the
individuals surveyed in-
tended to get vaccinated
against influenza. This is
higher than the current
surveyed population cov-
erage rate (23.7%), indi-
cating that more people
intend to be vaccinated
during the winter of 2005/
2006 than were vaccinated
during winter 2004/2005.
There is a gap between the
vaccination intentions and
the actual vaccination acts,
indicating an unfulfilled
vaccination potential in
Europe. By activating the
correct drivers to vaccina-
tion with the population
and by dealing with the
vaccination barriers, it can
be expected that higher
coverage rates could be
achieved rapidly. A realis-
tic vaccination coverage
rate target could be set at
the level of vaccination
intentions expressed by the
population. According to
this survey, the coverage
target for 2005/2006 could
be set at 31% of the popu-
lation over 15 years of age.
The most important
predisposing factors affect-
ing vaccination rate are age (advanced age) and suffering
from chronic illness. The assumption that health care
workers have a higher vaccination rate than non health care
workers has not been confirmed. Their vaccination rate is,
with 23%, extremely low. Rehmet showed this tendency
(7% of health care workers were immunized in 1999) [27] as
well as Gil (20% were immunized in 2004) [28] and Hof-
mann [29]. This in opposite to the fact that the healthcare
professionals are at increased risk of influenza infection and
could potentially transmit the disease to fragile patients in
hospitals. Szucs showed that physicians have a higher vac-
cination rate (12.1%) than nurses (9.8%) [30].
We explored the drivers and barriers that could im-
prove influenza vaccine uptake in Europe. The survey
demonstrated that there are some clear reasons driving
vaccination for people who had an influenza vaccine. The
four most important mentioned were influenza being con-
sidered as a serious illness, family doctor or nurse actively
recommending vaccination, not wanting to infect family
Table 7
Questions about the vaccination: options encouraging vaccination against influenza.
The most frequently stated reasons (%) 02–04 04/05
If my family doctor/nurse recommended it to me 53.1a 46.9a
If I had more information on the vaccine regarding
efficacy and tolerance
32.1a 56.0a
If I knew more about the disease 26.7a 22.9a
If there were other ways of administering the vaccine
(oral, injections without a needle, etc…)
22.1 18.2
If I could be vaccinated at work 20.9 17.7
If my pharmacist recommended it to me 17.7 15.7
If it were cheaper or reimbursed 16.7 14.2
Chronic illness, under 65 years
If my family doctor/nurse recommended it to me 57.9
If I had more information on the vaccine regarding
efficacy and tolerance
33.7
If I knew more about the disease 30.6
If I could be vaccinated at work 25.0
If there were other ways of administering the vaccine
(oral, injections without a needle, etc…)
25.0
Working in medical field
If my family doctor/nurse recommended it to me 38.3
If I could be vaccinated at work 28.1
If I had more information on the vaccine regarding
efficacy and tolerance
20.2
If I knew more about the disease 19.2
If there were other ways of administering the vaccine
(oral, injections without a needle, etc…)
18.6
Older age, >65 years
If my family doctor/nurse recommended it to me 57.0
If I had more information on the vaccine regarding
efficacy and tolerance
23.7
If I knew more about the disease 23.7
If my pharmacist recommended it to me 20.2
If there were other ways of administering the vaccine
(oral, injections without a needle, etc…)
20.0
a Main three reasons stated amongst the different groups
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and friends and advanced age. The three main reasons for
not being vaccinated noted by those who have never been
vaccinated were: not expecting to catch influenza, not
having considered vaccination before and not having re-
ceived a recommendation by the family doctor or nurse to
be vaccinated. Both those being vaccinated and those who
have never been vaccinated note the doctor or nurse as
people playing a key role in public vaccination behaviour.
In the vaccinated group, healthcare professionals were able
to stimulate their patients towards vaccination by active
recommendation whereas in the non-vaccinated group,
omitting to recommend vaccination had a negative effect
on uptake. This clearly indicates the key role of healthcare
workers in vaccination uptake.
The family doctor is the most important person to
encourage people to be vaccinated against influenza; this
was also confirmed by Kamal [4], Kroneman [3] and
Rehmet [26]. Rehmet demonstrated that having a family
doctor increased the vaccination rate and that family
physicians performed 93% of the vaccinations. This indi-
cates that active recommendation from the family doctor
could really impact vaccine uptake. This is confirmed by
the surveyed people themselves, who state that an active
recommendation by their doctor would indeed encourage
them to be vaccinated (Table 8).
Further reference to table 8 shows that people would
like more information on influenza as a disease and on
influenza vaccines, so as to be vaccinated. Effective and
educational communication campaigns by recognized
authorities on influenza and influenza prevention could
fill this information gap and provide the requested
information to the public.
We also suggest that fam-
ily doctors be better in-
formed about the
influenza vaccine and the
disease itself, so that they
can actively inform their
patients about these topics
and recommend vaccina-
tion accordingly. This
could lead to an increase
in vaccine uptake.
In May 2003, through
the World Health Assem-
bly, the WHO passed a
resolution on the preven-
tion and control of influ-
enza pandemics and
annual epidemics. The
resolution urges Member
States where national
influenza recommenda-
tions for people at risk
(elderly and persons with
underlying diseases) exist,
to attain a vaccination coverage rate in the elderly of 50%
in 2006 and 75% in 2010 [31]. This resolution was rein-
forced by the WHO in 2005 [32] and the WHO vaccina-
tion coverage rate objectives endorsed by the Commission
of the European Communities [33].
In the context of this paper, we compared these vac-
cination coverage objectives with the situation in the five
countries, considering that the elderly population was the
population recommended for vaccination (i.e., those aged
65 and over). When referring to figure 3, people aged 65
and over match the 50% objective for 2006. Efforts to
increase vaccination coverage rate and match the objec-
tive for 2010 will however be necessary. A stronger
implementation of the current recommendations is nee-
ded and doctors should be informed of their importance in
this process. To improve the situation doctors need to be
educated on influenza and influenza vaccine benefits in
order to be vaccinated themselves first. Then they must be
informed that they should actively recommend the vac-
cine, as well as inform their patients on vaccine efficacy
and tolerance and the disease itself. Active recommen-
dation to the target groups could really impact vaccine
uptake. They should also be made aware of the fact that
patients are willing to receive information on the diseases
and vaccines. In general, more education on disease and
influenza vaccine benefits should be made available.
These results are consistent with other studies show-
ing the importance of physicians or health-care personnel
in motivating people for influenza vaccination [3, 9, 34].
Efforts must be made at all national and international
levels to increase the coverage according to WHO
Table 8
Likelihood of receiving influenza vaccination among high-risk individuals between countries
(expressed in crude and adjusteda odds ratios, incl. 95% confidence intervals) in the 2004/2005 season.
Any high
risk group
Age > 65
yearsb
Healthcare
worker
People with
chronic illness
All countries
Crude 7.8 (7.1; 8.7) 10.0 (9.0; 11.2) 1.0 (0.8; 1.2) 5.0 (4.4; 5.6)
Adjusted 3.7 (3.3; 4.2) 3.1 (2.6; 3.7) 1.7 (1.4; 2.1) 3.1 (2.8; 3.5)
UK
Crude 12.9 (10.2; 16.4) 14.1 (10.8; 18.39 0.9 (0.6; 1.4) 8.6 (6.5; 11.3)
Adjusted 6.0 (4.5; 7.9) 4.2 (2.3; 6.2) 1.3 (0.8; 2.1) 6.9 (5.0; 9.4)
Germany
Crude 5.1 (4.1; 6.3) 6.2 (4.9; 7.8) 0.9 (0.6; 1.3) 3.6 (2.9; 4.5)
Adjusted 2.5 (1.9; 3.2) 1.9 (1.3; 2.7) 1.5 (1.0; 2.3) 2.3 (1.8; 3.0)
Italy
Crude 10.2 (8.0; 13.0) 9.5 (7.4; 12.3) 0.9 (0.5; 1.8) 7.7 (5.9; 10.2)
Adjusted 4.7 (3.5; 6.5) 2.5 (1.7; 3.7) 1.6 (0.8; 2.9) 4.4 (3.3; 6.0)
France
Crude 10.2 (8.0; 13.0) 17.4 (13.2; 22.7) 0.8 (0.5; 1.3) 4.8 (3.7; 6.2)
Adjusted 4.1 (3.0; 5.5) 5.3 (3.4; 8.2) 2.4 (1.4; 3.9) 2.7 (2.0; 3.6)
Spain
Crude 5.1 (4.0; 6.4) 8.3 (6.2; 11.0) 1.4 (0.9; 2.2) 3.1 (2.4; 4.1)
Adjusted 2.8 (2.1; 3.6) 3.2 (2.1; 4.7) 1.6 (1.0; 2.6) 2.1 (1.6; 2.9)
a Adjusted odds ratios are adjusted for age and gender; bAdjusted for gender
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objectives. Further research should be performed to pro-
vide consistent comparison between different countries
and seasons over time.
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Appendix
AVENTIS PASTEUR MSD Flu Vaccination in Europe 2003 MASTER QUESTIONNAIRE
1. Have you had a flu vaccine this winter? 
(READ. ONE RESPONSE ONLY)
• Yes, and it was the first time that I had ever been vaccinated against the flu 1→ Go to Q2 
• Yes, and I have been vaccinated in previous years against the flu ................. 2→ Go to Q1a
• No, but I have been vaccinated against the flu in the past .............................. 3→ Go to Q1b
• No, and I have never been vaccinated against the flu .................................... 4→ Go to Q4
IF CODE 2 IN Q1, ASK Q1a
1a. Do you get vaccinated against the flu every year?
 Yes ...................... 1 Go to Q2
 No ........................ 2 Go to Q1b
Dont know............ 3 Go to Q1b
IF CODE 3 IN Q1 or IF CODE 2 or 3 IN Q1a, ASK Q1b 
1b. Did you get vaccinated last winter (the winter of 2002/2003)?
 Yes ...................... 1
No ........................ 2
Don’t know........... 3
IF CODE 1 OR 2 IN Q1, ASK Q2
2. Why did you get vaccinated this winter?
(READ LIST. SELECT ALL THAT APPLY)
• Because it's free : the Social Security (to be adapted to each country; eg : UK - National 
Health Service ) pays for it ........................................................................................... 01
• So that I do not pass the flu bug to my family and friends............................................ 02
• Because the flu is a serious illness and I did not want to get it .................................... 03
• The doctor at work offered to do it for me .................................................................... 04
• My family doctor advised me to do it (GERMANY, ITALY, SPAIN).............................. 05
• My family doctor / nurse advised me to do it (UK ONLY)............................................. 06
• My pharmacist (chemist in UK) advised me to do it ..................................................... 23
• Because of my age....................................................................................................... 07
• Because I am not in very good health .......................................................................... 08
• To prevent the flu from interrupting my professional activities ..................................... 09
• Because it is required / indicated for my job................................................................. 10
• Because I got the flu last year ...................................................................................... 24
• Other reasons............................................................................................................... 11
• Don't know/ no answer (DO NOT READ)..................................................................... 99
(Continued next page)
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TO ALL
5. Here are some opinions which might be expressed about FLU VACCINE. For each of these please
tell me whether you, personally, totally agree, quite agree, don’t really agree, or don't agree at all.
(READ AND ROTATE A-F). 
1 answer per line
Totally
agree
Quite
agree
Don’t
really
agree
Don’t
agree
at all 
Don't
know
a. You can catch the flu even if you've been vaccinated 
against it 1 2 3 4 5
b. If you catch the flu after having had the vaccine, the 
infection is less severe 1 2 3 4 5
c. The side effects associated with the vaccine (fever,
headache,…) are negligeable 1 2 3 4 5
d. If you have the vaccine you won't catch the flu 1 2 3 4 5
e. The flu vaccine is not useful if you are in good health 1 2 3 4 5
f. It is important to get the flu vaccine each year 1 2 3 4 5
IF CODE 4 IN Q1, ASK Q4
4. Why do you not get vaccinated against the flu ?
(READ LIST. SELECT ALL THAT APPLY)
• I don’t think I am very likely to catch the flu .............................................................. 01
• I thought about it but I didn’t end up getting vaccinated ........................................... 25
• My family doctor has never recommended it to me.................................................. 02
• My doctor at work has never recommended it to me................................................ 26
• My pharmacist has never recommended it to me..................................................... 27
• It is not a serious enough illness .............................................................................. 03
• I do not think the vaccine is effective enough........................................................... 04
• I do not like injections/needles.................................................................................. 05
• I have never considerered it before .......................................................................... 06
• There is a new treatment which helps cure the flu .................................................. 07
• I am too young to be vaccinated............................................................................... 08
• I am against vaccinations ......................................................................................... 09
• It is too complicated to get vaccinated (INTERVIEWER, READ ONLY IF
NECESSARY -- appointment with the doctor to get the prescription, buying the 
vaccine at the chemist, vaccinated by the doctor)  (ITALY, and SPAIN).................. 10
• It is too complicated to get vaccinated (UK and GERMANY) ................................... 11
• It is too expensive, it is not reimbursed .................................................................... 12
• Other reasons........................................................................................................... 13
• Don't know/ no answer (DO NOT READ) ................................................................. 99
IF CODE 3 IN Q1, ASK Q3
3. And why didn’t you get vaccinated against the flu this winter?
(READ LIST. SELECT ALL THAT APPLY)
• I didn’t really think about it, I forgot to do it .............................................................. 01
• My family doctor did not recommend it to me........................................................... 02
• My doctor at work did not recommend it to me......................................................... 28
• My pharmacist did not recommend it to me.............................................................. 29
• I got the flu before, even though I had been vaccinated .......................................... 03
• I had side-effect problems with a previous flu vaccine ............................................. 04
• There is a new treatment which helps cure the flu .................................................. 05
• It is too expensive, it is not reimbursed .................................................................... 06
• I do not think the vaccine is effective enough........................................................... 30
• I do not like injections/needles.................................................................................. 31
• I don’t feel concerned .............................................................................................. 32
• Other reasons........................................................................................................... 07
• Don't know/ no answer (DO NOT READ) ................................................................. 99
(Continued next page)
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8. Do you suffer from a chronic illness (like heart or lung disease, diabetes or others)? 
• Yes ..........................1  Q8a and then Q8b 
• No ............................2  Q9 
• Don't know...............3  Q9 
TO ALL 
9 Do you work in the medical field? 
• Yes ..........................1  Q9a  
• No ............................2  demographics 
• Don't know...............3  demographics 
6. Do you intend to get vaccinated against the flu next winter (the winter of 2004/2005)? 
• Yes ...........................................................................................................1
• No .............................................................................................................2
• Don't know................................................................................................3
7. In general, and whether or not you have been vaccinated this winter, please tell me which of the 
following options would encourage you to be vaccinated against the flu ? 
(READ LIST. SELECT ALL THAT APPLY)
• If I could be vaccinated at work ..............................................................................................01
• If my family doctor recommended it to me (GERMANY, ITALY, SPAIN) ...............................02
• If my doctor / nurse recommended it to me (UK ONLY).........................................................03
• If my pharmacist recommended it to me ................................................................................14
• If there were other ways of administering the vaccine (orally, injection without a 
needle, etc… ) ........................................................................................................................04
• If it were cheaper or reimbursed (GERMANY, ITALY, SPAIN)...............................................05
• If it were cheaper (UK ONLY).................................................................................................06
• If I had more information on the vaccine regarding efficacy ...................................................15
• If I had more information on the vaccine regarding tolerance.................................................16
• If I knew more about the disease (who gets it, the severity of it, etc.) ....................................08
• I would not change my mind, I would never be vaccinated (DO NOT READ) ........................09
• Other (specify __________) ...................................................................................................10
• Don’t know/ no answer (DO NOT READ) ..............................................................................99
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